Recent Quotes (30 days)

You have no recent quotes
chg | %


(Public, TSE:IM)   Watch this stock  
Find more results for IM
- Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 1.33
Open     -
Vol / Avg. 0.00/3,204.00
Mkt cap 45.07M
P/E     -
Div/yield     -
EPS -0.76
Shares 62.59M
Beta 0.61
Inst. own 9%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -73.94% -105.18%
Operating margin -46.99% -80.09%
EBITD margin - -75.42%
Return on average assets -45.35% -40.24%
Return on average equity -213.57% -129.83%
Employees 121 -
CDP Score - -


100-1370 Sony Place
+1-204-4807090 (Phone)
+1-204-4807071 (Fax)

Website links


IMRIS Inc. (IMRIS) designs, manufactures and markets the VISIUS Surgical Theatre. Its VISIUS Surgical Theatre is a multifunctional surgical environment that provides intraoperative vision to clinicians to assist in decision-making and precision in treatment. The VISIUS Surgical Theatre can incorporate magnetic resonance (MR) imaging, computed tomography (CT) imaging and x-ray angiography in various configurations. IMRIS sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. Its VISIUS iMRI provides imaging using Siemens 1.5T (tesla) and 3T MR core technology to enable imaging capabilities, including spectroscopy, fMRI and DTI. Its SYMBIS Surgical System is an MR and CT-compatible image guided surgical robot. Its VISIUS iCT is a specialized multifunctional surgical theater that brings CT image quality with low dose management directly to patients in the operating room.